BackCorvus Pharmaceuticals Overview

Corvus Pharmaceuticals Total Assets

Latest total assets for CRVS: $220M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$223.88M
↑ 178.20% YoYΔ $143.40M vs prior year quarter

Peer trimmed avg / median

Loading

Corvus Pharmaceuticals Total Assets History

Loading

Corvus Pharmaceuticals vs. peers: Total Assets Comparison

Loading

Corvus Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Corvus Pharmaceuticals (CRVS) FAQ

As of the most recent data (September 2026), CRVS shows a total assets of $220M. That compares with $80M in the prior-year period — up 178.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CRVS's total assets is now $220M (was $80M) — a 178.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Corvus Pharmaceuticals is outperforming or lagging.

Tracking CRVS's total assets over time shows whether Corvus Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $220M That compares with $80M in the prior-year period — up 178.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Corvus Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $220M) with ownership activity and broader fundamentals.

Corvus Pharmaceuticals's total assets is $220M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.